XFOR
X4 Pharmaceuticals, IncCompany with tickers: XFOR
CIK
1501697
CUSIP
98420X202
Shares Outstanding
94,319,696
13F Activity (30d)
66 filings
65 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-12 | KIRSKE DAVID |
Chief Financial Officer | Sell | 16,961 |
| 2026-01-01 | WYZGA MICHAEL S |
Director | Award | 110,000 |
| 2026-01-01 | Bridger Gary |
Director | Award | 110,000 |
| 2026-01-01 | de Craecker Francoise |
Director | Award | 110,000 |
| 2026-01-01 | Stewart Murray |
Director | Award | 110,000 |
| 2025-10-29 | KIRSKE DAVID |
Chief Financial Officer | Award | 1,552,769 |
| 2025-10-29 | Volpone John |
President | Award | 2,329,154 |
| 2025-10-29 | Craig Adam R |
Director, Executive Chairman | Award | 2,329,154 |
| 2025-10-23 | Craig Adam R |
Director, Executive Chairman | Buy | 86,206 |
| 2025-08-14 | KIRSKE DAVID |
Chief Financial Officer | Award | 352,800 |
| 2025-08-14 | Volpone John |
President | Award | 529,201 |
| 2025-08-14 | KIRSKE DAVID |
Chief Financial Officer | Award | 193,254 |
| 2025-08-14 | Craig Adam R |
Director, Executive Chairman | Award | 529,201 |
| 2025-08-14 | Craig Adam R |
Director, Executive Chairman | Award | 289,881 |
| 2025-08-14 | Volpone John |
President | Award | 289,881 |
| 2025-08-12 | KIRSKE DAVID |
Chief Financial Officer | Award | 1,073,249 |
| 2025-08-12 | Craig Adam R |
Director, Executive Chairman | Other | 0 |
| 2025-08-12 | KIRSKE DAVID |
Chief Financial Officer | Other | 0 |
| 2025-08-12 | Craig Adam R |
Director, Executive Chairman | Award | 1,609,873 |
| 2025-08-12 | Volpone John |
President | Award | 1,609,873 |
| 2025-08-12 | Volpone John |
President | Other | 0 |
| 2025-06-09 | WYZGA MICHAEL S |
Director | Award | 1,500 |
| 2025-06-09 | Stewart Murray |
Director | Award | 1,500 |
| 2025-06-09 | MCGIRR DAVID W J |
Director | Award | 1,500 |
| 2025-06-09 | Bridger Gary |
Director | Award | 1,500 |
| 2025-06-09 | Woods Keith |
Director | Award | 1,500 |
| 2025-06-09 | de Craecker Francoise |
Director | Award | 1,500 |
| 2025-05-20 | Thoren Natasha Fay |
Chief Legal Officer | Other | 0 |
| 2025-05-20 | Thoren Natasha Fay |
Chief Legal Officer | Award | 3,333 |
| 2025-05-20 | Thoren Natasha Fay |
Chief Legal Officer | Other | 6,984 |
| 2025-05-16 | Baldry Mark |
Chief Commercial Officer | Buy | 1,032 |
| 2025-02-12 | Ragan Paula |
Director | Award | 2,250,000 |
| 2025-02-12 | Mostafa Adam S. |
Chief Financial Officer | Award | 850,000 |
| 2025-02-12 | Baldry Mark |
Chief Commercial Officer | Award | 600,000 |
| 2025-02-12 | Arbet-Engels Christophe |
Chief Medical Officer | Award | 850,000 |
| 2025-02-12 | DiBiase Mary |
Chief Operating Officer | Award | 650,000 |
| 2025-01-24 | Mostafa Adam S. |
Chief Financial Officer | Sell | 74,773 |
| 2025-01-24 | Ragan Paula |
Director | Sell | 76,473 |
| 2025-01-24 | DiBiase Mary |
Chief Operating Officer | Sell | 22,258 |
| 2025-01-24 | Arbet-Engels Christophe |
Chief Medical Officer | Sell | 11,624 |
| 2025-01-24 | Baldry Mark |
Chief Commercial Officer | Sell | 29,159 |
| 2025-01-23 | Mostafa Adam S. |
Chief Financial Officer | Award | 74,773 |
| 2025-01-23 | DiBiase Mary |
Chief Operating Officer | Award | 61,178 |
| 2025-01-23 | Ragan Paula |
Director | Award | 169,940 |
| 2025-01-23 | Arbet-Engels Christophe |
Chief Medical Officer | Award | 25,831 |
| 2025-01-23 | Baldry Mark |
Chief Commercial Officer | Award | 74,773 |
| 2024-11-15 | Baldry Mark |
Chief Commercial Officer | Buy | 13,404 |
| 2024-11-15 | Ragan Paula |
Director | Sell | 31,897 |
| 2024-10-15 | Ragan Paula |
Director | Sell | 31,897 |
| 2024-10-07 | Baldry Mark |
Chief Commercial Officer | Sell | 11,127 |
Showing 1–50 of 253 transactions